TMED vs. RMRC
TMED (T. Rowe Price Health Care ETF) and RMRC (ARMOR Core Risk-Managed ETF) are both exchange-traded funds - TMED is a Health & Biotech Equities fund actively managed by T. Rowe Price, while RMRC is a Actively Managed fund actively managed by Exchange Traded Concepts. Both are actively managed. Their 0.66 correlation means they have sometimes moved together and sometimes differently. TMED charges 0.44%/yr vs 0.60%/yr for RMRC.
Performance
TMED vs. RMRC - Performance Comparison
Loading charts...
Returns By Period
TMED
- 1D
- 0.28%
- 1M
- -2.90%
- 6M
- 13.93%
- YTD
- 14.31%
- 1Y
- 41.69%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 31.40%
RMRC
- 1D
- 0.61%
- 1M
- 0.49%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $203.54K | $109.38K | $148.33K | |
| $590.48K | $387.83K | $177.93K |
TMED vs. RMRC - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
TMED T. Rowe Price Health Care ETF | 12.19% |
RMRC ARMOR Core Risk-Managed ETF | 3.29% |
Correlation
The correlation between TMED and RMRC is 0.66, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Feb 24, 2026 | 0.66 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. RMRC — Risk / Return Rank
TMED
RMRC
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
TMED vs. RMRC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and ARMOR Core Risk-Managed ETF (RMRC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TMED | RMRC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.39 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 3.77 | — | — |
| Martin ratioReturn relative to average drawdown | 12.83 | — | — |
Loading charts...
Drawdowns
TMED vs. RMRC - Drawdown Comparison
The maximum TMED drawdown since its inception was -11.11%, which is greater than RMRC's maximum drawdown of -6.57%. Use the drawdown chart below to compare losses from any high point for TMED and RMRC.
Loading charts...
Drawdown Indicators
| TMED | RMRC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.11% | -6.57% | -4.54% |
Max Drawdown (1Y)Largest decline over 1 year | -11.11% | — | — |
Current DrawdownCurrent decline from peak | -3.98% | -0.31% | -3.67% |
Average DrawdownAverage peak-to-trough decline | -2.42% | -1.54% | -0.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.26% | — | — |
Volatility
TMED vs. RMRC - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | RMRC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.81% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 14.06% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.29% | 10.10% | +8.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.11% | 10.10% | +8.01% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.11% | 10.10% | +8.01% |
TMED vs. RMRC - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is lower than RMRC's 0.60% expense ratio.
Dividends
TMED vs. RMRC - Dividend Comparison
TMED's dividend yield for the trailing twelve months is around 0.48%, less than RMRC's 0.58% yield.
| Position | TTM | 2025 |
|---|---|---|
RMRC ARMOR Core Risk-Managed ETF | 0.58% | 0.00% |
TMED T. Rowe Price Health Care ETF | 0.48% | 0.54% |
Frequently Asked Questions
TMED and RMRC have a correlation of 0.66, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TMED is cheaper with a 0.44% expense ratio, compared with 0.60% for RMRC.
RMRC has the higher dividend yield at 0.58%, compared with 0.48% for TMED.
TMED is categorized as Health & Biotech Equities, while RMRC is Actively Managed. They also come from different issuers: T. Rowe Price and Exchange Traded Concepts. Their fees differ too: 0.44% for TMED and 0.60% for RMRC.
Find the right allocation for TMED and RMRC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer